Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Intermediate and high-risk clonal hematopoiesis in germline predisposition families

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAdoración BlancoDVDavid ValcárcelAJAndrés Jerez

Discussion

Loading...

Member takes

Overview

Observational analysis found 37.5% of relatives carry germline variants in myelodysplastic neoplasms, suggesting significant clonal hematopoiesis risk.

Key Points

  • Clonal hematopoiesis indicating potential malignancy was observed in 37.5% of relatives carrying germline variants.
  • Targeted next-generation sequencing revealed pathogenic variants in 24% of assessed individuals from families with myeloid neoplasms.
  • Analysis included Sanger sequencing and longitudinal studies evaluating clonal evolution in family carriers over time.
  • Findings highlight the need for increased screening in families with known germline predispositions to myeloid neoplasms.

Cite This Study

Blanco et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d79fhttps://doi.org/10.1182/blood-2025-2058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy2025
  2. 2Screening for clonal hematopoiesis in patients with β-hemoglobinopathies who are candidates to transplant approaches2025 · 1 citations
  3. 3Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations2025 · 4 citations
  4. 4Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults2025
  5. 5Characterization of antecedent clonal hematopoiesis (CH) mutations in lymphoid and plasma cell neoplasms2025 · 1 citations